134 related articles for article (PubMed ID: 8488717)
21. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of phoP and rpoS mutants of Salmonella enterica serovar Typhi as attenuated typhoid vaccine candidates: virulence and protective immune responses in intranasally immunized mice.
Lee HY; Cho SA; Lee IS; Park JH; Seok SH; Baek MW; Kim DJ; Lee SH; Hur SJ; Ban SJ; Lee YK; Han YK; Cho YK; Park JH
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):310-8. PubMed ID: 17725620
[TBL] [Abstract][Full Text] [Related]
23. Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method.
Jang MS; Sahastrabuddhe S; Yun CH; Han SH; Yang JS
Microb Pathog; 2016 Aug; 97():19-26. PubMed ID: 27216239
[TBL] [Abstract][Full Text] [Related]
24. Safety and antigenicity of typhoid-Shigella sonnei vaccine (strain 5076-1C).
Tramont EC; Chung R; Berman S; Keren D; Kapfer C; Formal SB
J Infect Dis; 1984 Feb; 149(2):133-6. PubMed ID: 6366077
[TBL] [Abstract][Full Text] [Related]
25. Specific immune response in humans following rectal delivery of live typhoid vaccine.
Forrest BD; Shearman DJ; LaBrooy JT
Vaccine; 1990 Jun; 8(3):209-12. PubMed ID: 2363299
[TBL] [Abstract][Full Text] [Related]
26. Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.
Wahid R; Salerno-Gonçalves R; Tacket CO; Levine MM; Sztein MB
Vaccine; 2007 Feb; 25(8):1416-25. PubMed ID: 17182155
[TBL] [Abstract][Full Text] [Related]
27. Vi Capsular Polysaccharide Produced by Recombinant
Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
[TBL] [Abstract][Full Text] [Related]
28. Systemic and intestinal immunities after different typhoid vaccinations.
Sarasombath S; Banchuin N; Sukosol T; Vanadurongwan S; Rungpitarangsi B; Dumavibhat B
Asian Pac J Allergy Immunol; 1987 Jun; 5(1):53-61. PubMed ID: 3620049
[TBL] [Abstract][Full Text] [Related]
29. Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.
Levine MM; Hone D; Tacket C; Ferreccio C; Cryz S
Res Microbiol; 1990; 141(7-8):807-16. PubMed ID: 2101470
[TBL] [Abstract][Full Text] [Related]
30. Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain.
Tacket CO; Hone DM; Losonsky GA; Guers L; Edelman R; Levine MM
Vaccine; 1992; 10(7):443-6. PubMed ID: 1609547
[TBL] [Abstract][Full Text] [Related]
31. Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine.
Forrest BD; LaBrooy JT; Robinson P; Dearlove CE; Shearman DJ
Infect Immun; 1991 Mar; 59(3):1206-9. PubMed ID: 1997425
[TBL] [Abstract][Full Text] [Related]
32. A preliminary report on the immunological responses after oral vaccine (Ty 21a).
Sirianni MC; Turbessi G; Scarpati B; Russo G; Mascellino MT; Aiuti F
Boll Ist Sieroter Milan; 1984 Sep; 63(4):352-6. PubMed ID: 6394032
[TBL] [Abstract][Full Text] [Related]
33. Immune response of infants and preschool children to typhoid vaccine given intradermally or subcutaneously.
Mohandas V; Cherian T; Sridharan G; Simoes EA; Pereira SM; John TJ
BMJ; 1989 Jan; 298(6667):162-3. PubMed ID: 2493838
[No Abstract] [Full Text] [Related]
34. IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine.
Tagliabue A; Villa L; De Magistris MT; Romano M; Silvestri S; Boraschi D; Nencioni L
J Immunol; 1986 Sep; 137(5):1504-10. PubMed ID: 3489034
[TBL] [Abstract][Full Text] [Related]
35. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
36. Oral Typhoid Vaccination With Live-Attenuated Salmonella Typhi Strain Ty21a Generates Ty21a-Responsive and Heterologous Influenza Virus-Responsive CD4+ and CD8+ T Cells at the Human Intestinal Mucosa.
Pennington SH; Thompson AL; Wright AK; Ferreira DM; Jambo KC; Wright AD; Faragher B; Gilmour JW; Gordon SB; Gordon MA
J Infect Dis; 2016 Jun; 213(11):1809-19. PubMed ID: 26810369
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers.
Hohmann EL; Oletta CA; Miller SI
Vaccine; 1996 Jan; 14(1):19-24. PubMed ID: 8821644
[TBL] [Abstract][Full Text] [Related]
38. CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.
Tacket CO; Levine MM
Clin Infect Dis; 2007 Jul; 45 Suppl 1():S20-3. PubMed ID: 17582563
[TBL] [Abstract][Full Text] [Related]
39. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
Chau PY; Tsang RS
Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471
[TBL] [Abstract][Full Text] [Related]
40. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.
Levine MM; Herrington D; Murphy JR; Morris JG; Losonsky G; Tall B; Lindberg AA; Svenson S; Baqar S; Edwards MF
J Clin Invest; 1987 Mar; 79(3):888-902. PubMed ID: 3818953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
